Neurofilament light in CSF and serum is a sensitive marker for axonal white matter injury in MS

OBJECTIVE: In an ongoing, open-label, phase 1b study on the intrathecal administration of rituximab for progressive multiple sclerosis, an intraventricular catheter was inserted for drug delivery. The objective of this study was to characterize the limited white matter axonal injury evoked by cathet...

Descripción completa

Detalles Bibliográficos
Autores principales: Bergman, Joakim, Dring, Ann, Zetterberg, Henrik, Blennow, Kaj, Norgren, Niklas, Gilthorpe, Jonathan, Bergenheim, Tommy, Svenningsson, Anders
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4972001/
https://www.ncbi.nlm.nih.gov/pubmed/27536708
http://dx.doi.org/10.1212/NXI.0000000000000271

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4972001/
https://www.ncbi.nlm.nih.gov/pubmed/27536708
http://dx.doi.org/10.1212/NXI.0000000000000271

Ejemplares similares